Mittie Doyle
Chief Medical Officer; Director · 16 filings · Latest: Aug 28, 2026
Avalo Therapeutics, Inc.
Cullinan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AVTX | Mittie Doyle | Chief Medical Officer | May 5, 2026 | Sale | $16.00 | 1,679 | $26.9K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | May 5, 2026 | Option Exercise | $10.79 | 1,679 | $18.1K | 5,301 | |
AVTX | MITTIE DOYLE | — | May 6, 2026 | Proposed Sale | $16.26 | 54,508 | $886.3K | — | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 6, 2026 | Sale | $18.01 | 3,970 | $71.5K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 6, 2026 | Option Exercise | $12.65 | 3,970 | $50.2K | 7,592 | |
AVTX | MITTIE DOYLE | — | Apr 6, 2026 | Proposed Sale | $17.76 | 65,800 | $1.2M | — | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 1, 2026 | Sale | $16.00 | 679 | $10.9K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Apr 1, 2026 | Option Exercise | $8.04 | 679 | $5.5K | 4,301 | |
AVTX | Mittie Doyle | Chief Medical Officer | Mar 16, 2026 | Sale | $16.15 | 25,492 | $411.6K | 3,622 | |
AVTX | Mittie Doyle | Chief Medical Officer | Mar 16, 2026 | Option Exercise | $11.57 | 25,492 | $294.9K | 29,114 | |
AVTX | MITTIE DOYLE | — | Mar 16, 2026 | Proposed Sale | $15.80 | 29,529 | $466.6K | — |
← Previous
Page 2 of 2